ctrl K

Price Alert

Gyre Therapeutics Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

8.11

-0.11 (-1.34%)

At close: Aug 15, 2025, 3:59 PM

8.14

0.37%

After-hours: Aug 15, 2025, 04:04 PM EDT

Gyre Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.81M	33.51M	25.18M	44.35M
Short-Term Investments	14.86M	n/a	10.6M	2.5M
Long-Term Investments	24.57M	23.43M	7.39M	n/a
Other Long-Term Assets	4.46M	5.72M	-11.6M	-20.69M
Receivables	29.15M	16.84M	17.14M	1.82M
Inventory	6.34M	4.28M	6.12M	n/a
Other Current Assets	1.44M	1.04M	843K	2.81M
Total Current Assets	64.79M	57.22M	49.65M	51.48M
Property-Plant & Equipment	25.7M	23.78M	70K	3.71M
Goodwill & Intangibles	273K	1.7M	297K	20.76M
Total Long-Term Assets	60.62M	59.32M	238K	4.19M
Total Assets	125.41M	116.54M	84.75M	55.66M
Account Payables	108K	355K	122K	6.42M
Deferred Revenue	156K	79K	167K	230K
Short-Term Debt	713K	n/a	38K	1.98M
Other Current Liabilities	4.99M	7.91M	2.55M	195.12K
Total Current Liabilities	19.52M	20.05M	12.24M	14.16M
Long-Term Debt	n/a	n/a	n/a	408K
Other Long-Term Liabilities	5.67M	17.61M	55K	-408K
Total Long-Term Liabilities	7.49M	18.02M	294K	408K
Total Liabilities	27M	38.06M	12.54M	14.57M
Total Debt	1.6M	409K	613K	2.38M
Common Stock	86K	77K	64K	31K
Retained Earnings	-73.45M	-85.54M	7.39M	-402.69M
Comprehensive Income	501K	1.45M	2.27M	40.23M
Shareholders Equity	63.32M	-15.83M	42.52M	41.09M
Total Investments	39.43M	23.43M	17.99M	2.5M